CD117 (KIT) is a useful marker in the diagnosis of plasmablastic plasma cell myeloma.

Etan MarksYang ShiYanhua Wang

Published in: Histopathology (2017)

This study reveals that CD117 can be a useful marker to help differentiate PPCM from PBL and give the patient an appropriate prognosis and options for treatment.

Keyphrases

single cell
nk cells
stem cells
newly diagnosed
mesenchymal stem cells
combination therapy